JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A2600 (-)-Epigallocatechin gallate (EGCG)

Target: BACE

Summary: Antioxidant, antiangiogenic and antitumor agent

≥22.9 mg/mL
A3306 Chelerythrine Chloride

Target: PKC

Summary: PKC antagonist

insoluble in H2O; ≥19.2 mg/mL
B1287 Ro 31-8220

Target: PKC

Summary: pan-PKC inhibitor

Soluble in DMSO
B2191 Dequalinium Chloride

Target: PKC|Calcium-Activated Potassium (KCa) Channels

Summary: anti-tumor agent and PKC inhibitor

insoluble in H2O; insoluble in ETOH; insoluble in DMSO
A8830 ZIP (SCRAMBLED)

Summary: PKMζ inhibitor

≥192.8 mg/mL
B3709 Midostaurin (PKC412)

Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinB

Summary: PKC inhibitor

≥57.1 mg/mL
B6803 Rottlerin
1 Citation

Target: PKC|Ca2 /calmodulin-dependent protein kinases (CaMKs)|PRAK|MAPKAP-K2

Summary: PKC inhibitor

insoluble in EtOH; insoluble in H2O; ≥23.6 mg/mL
A8341 Go 6976

Target: PKC

Summary: PKCα/PKCβ1 inhibitor

≥15.77 mg/mL
A8342 GF 109203X
1 Citation

Target: PKC

Summary: Protein kinase C,MLCK,PKG and PKA inhibitor

insoluble in EtOH; insoluble in H2O; ≥20.6 mg/mL
A1670 Enzastaurin (LY317615)
2 Citation

Target: PKC

Summary: PKC beta inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥8.59 mg/mL